Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 2;7(1):8.
doi: 10.1186/s40748-021-00129-3.

Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis

Asteray Assmie Ayenew  1
Affiliations
Review

Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis

Asteray Assmie Ayenew. Matern Health Neonatol Perinatol. .

Abstract

Background: Transplacental or fetomaternal hemorrhage (FMH) may occur during pregnancy or at delivery and lead to immunization to the D antigen if the mother is Rh-negative and the baby is Rh-positive. This can result in hemolytic disease of the fetus and newborn (HDFN) in subsequent D-positive pregnancies. Therefore, the aim of this systematic review and meta-analysis was to estimate distribution of ABO and Rh (D) blood groups among pregnant women in Ethiopia.

Method: We searched PubMed, Google Scholar, EMBASE, Cochrane Library, HINARI, AFRO Library Databases, and African Online Journal databases for all available studies using the following keywords: "High rhesus (Rh(D)) negative frequency", "ABO blood group distribution", "haemolytic disease of the newborn (HDN)", "rh isoimmunization", "anti-RhD immunoglobulin", "D-negative pregnancies", "Frequency", "ABO and Rh blood group distribution", "feto-maternal hemorrhage", "rhesus D negative pregnant mothers", "kleihauer-betke test (KBT)", "Neonatal Hyperbilirubinemia", "non-sensitized RhD-negative pregnant women", "antenatal anti-D immunoglobulin prophylaxis", "Hemolytic disease of the newborn (alloimmunization), Ethiopia. The search string was developed using "AND" and "OR" Boolean operators. All published and unpublished observational studies reporting the distribution of ABO and Rh (D) blood groups among pregnant women in Ethiopia were included. The study participants were all pregnant women in Ethiopia, and the main outcome measure of this systematic review and meta-analysis was Rhesus D-negative blood type and ABO blood group distribution among pregnant women in Ethiopia. The data was extracted by the author (AAA) by using a standardized JBI data extraction format. Microsoft Excel (2016), and Stata version 11.0 (Stata Corporation, College Station, Texas, USA) software were used for data entry and analysis, respectively. The random effect model was used for estimating the pooled effects, and the publication bias was assessed by visual inspection of the funnel plots and objectively by using the Egger's test (i.e. p < 0.05).

Results: One hundred thirty-two articles were identified through electronic database searching. Of which, 34 were excluded due to duplication, 65 through review of titles and abstracts, and 22 full-text articles were excluded for not reporting the outcome variable and other reasons. Finally, 7 were included to estimate the distribution of ABO and Rh (D) blood groups among pregnant women in Ethiopia. The pooled distribution of Rh-negative blood group among pregnant women in Ethiopia was 10.8% (95%CI: 7.53-14.07, I2 = 85%, p < 0.001). In the ABO system, type O was the most prevalent 39.9% (37.51-42.38), followed by A (30.59% (26.00-35.18)), B (23.04% (20.03-26.05)), and AB the least (4.82%(3.17-6.47)), in the pattern O > A > B > AB.

Conclusion: The pooled distribution of Rh-negative blood group among pregnant women in Ethiopia was high. Rh alloimmunization remains a major factor responsible for perinatal morbidity in Ethiopia and may result in the compromise of the woman's obstetric care due to the unaffordability of anti-D immunoglobulin. There is the urgent need for the implementation of universal access to anti-D immunoglobulin for the Rh-negative pregnant population in Ethiopia.

Keywords: Anti-D; Ethiopia; Management; Rh-negative women; Rhesus isoimmunization; Universal access.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of study selection for systematic review and meta-analysis of the distribution of ABO and Rh-Negative blood groups among pregnant women in Ethiopia
Fig. 2
Fig. 2
Forest Plot for the pooled distribution of Rh-negative blood groups among pregnant women in Ethiopia, 2020
Fig. 3
Fig. 3
Funnel plot with 95% confidence limits of the pooled distribution of Rh-negative blood groups among pregnant women in Ethiopia, 2020
Fig. 4
Fig. 4
Sensitivity analysis of the pooled distribution of Rh-negative blood groups among pregnant women in Ethiopia, 2020
Fig. 5
Fig. 5
Forest Plot for the pooled distribution of O blood group among pregnant women in Ethiopia, 2020
Fig. 6
Fig. 6
Forest Plot for the pooled distribution of A blood group among pregnant women in Ethiopia, 2020
Fig. 7
Fig. 7
Forest Plot for the pooled distribution of B blood group among pregnant women in Ethiopia, 2020
Fig. 8
Fig. 8
Forest Plot for the pooled distribution of AB blood group among pregnant women in Ethiopia, 2020
See this image and copyright information in PMC

References

    1. EAea NAGAMUTHU. Prevalence of rhesus negativity among pregnant women. Int J Res Med Sci. 2017;4:3305–3309.
    1. Hitzeroth HW, Op’t Hof J. On the prevention of rhesus immunisation in the RSA. South Afr Med J. 1988;74(10):502–506. - PubMed
    1. Greer JP, Arber DA, Glader BE, List AF, Means RM, Rodgers GM. Wintrobe’s clinical hematology: Lippincott Williams & Wilkins. 2018.
    1. Pourazar A, Homayouni V, Rezaei A, Andalib A, Oreizi F. The assessment of feto-maternal hemorrhage in an artificial model using anti-D and anti-fetal hemoglobin antibody by flow cytometry. Iran Biomed J. 2008;12(1):43–48. - PubMed
    1. Lafferty JD, Raby A, Crawford L, Linkins LA, Richardson H, Crowther M. Fetal-maternal hemorrhage detection in Ontario. Am J Clin Pathol. 2003;119(1):72–77. doi: 10.1309/3U97V7327JBDPAYN. - DOI - PubMed

LinkOut - more resources